Distribution of the parotid salivary gland tumors and key aspects of their diagnosis
DOI:
https://doi.org/10.57231/j.idmfs.2024.3.3.007Keywords:
tumors of the salivary glands, parotid salivary gland, diagnosis, epidemiology, radiomic analysis, fine needle aspiration biopsy, magnetic resonance imaging, histological examinationAbstract
Neoplasms of the salivary glands are among the most difficult in maxillofacial surgery for diagnosis and treatment. Tumors are more often benign and localized in the parotid salivary gland (PSG) – up to 80%. The peculiarities of the localization and anatomical structure of the PSG largely determine the requirements for a set of diagnostic measures and surgical treatment tactics. This review presents an analysis of the data from the scientific literature devoted to the aspects of the diagnosis of PSG neoplasms and the systematization of the problems of pathology differentiation.
References
Бычков Д.В., Батороев Ю.К., Вязьмин А.Я. Проблемы дооперационной диагностики опухолей слюнных желез // БМЖ. – 2011. – №6. – С. 33-36.
Иорданишвили А.К., Лобейко В.В. Распространенность заболеваний слюнных желез у взрослого человека в разные возрастные периоды // Клиническая геронтология. 2014. – №20 (11-12). – С. 14-19.
Кондратьева Т.Т. Цитологические аспекты дифференциальной диагностики новообразований в области головы и шеи: авторефер. дис. … д-ра мед. наук. — М., 1992. — 46 с.
Кузьмина Е.В., Сотникова М.В., Боровой В.Н., Наконечный Д.А. Проблемы диагностики новообразований слюнных желез. – Клиническая стоматология. – 2023; 26 (3): 60-69.
Тараканова О.В., Славнова Е.Н. Цитологическая диагностика опухолей слюнных желез. Онкология. Журнал им. П.А. Герцена. 2022;11(5):78 88.
Abbate, V.; Orabona, G.D.A.; Barone, S.; Troise, S.; Bonavolontà, P.; Pacella, D.; Iaconetta, G.; Califano, L. Relevance of Inflammatory Biomarkers in Salivary Gland Cancers Management. Eurasian J. Med. Oncol. 2021, 5, 311-317.
Alsanie I, Rajab S, Cottom H, et al. Distribution and Frequency of Salivary Gland Tumours: An International Multicenter Study. Head Neck Pathol. 2022;16(4):1043-1054.
Atamaniuk V, Chen J, Obrzut M, et al. High-frequency shear wave MR elastography of parotid glands: custom driver design and preliminary results. Sci Rep. 2024;14(1):24496. Published 2024 Oct 18.
Cheng, G.; Liu, F.; Niu, X.; Fang, Q. Role of the pretreatment neutrophil-to-lymphocyte ratio in the survival of primary parotid cancer patients. Cancer Manag. Res. 2019, 11, 2281–2286.
da Silva L. P., Serpa M. S., Viveiros S. K., Sena D. A. C., de Carvalho Pinho R. F., de Abreu Guimarães L. D., de Sousa Andrade E. S., Dias Pereira J. R., Silveira M., Sobral A. P. V., de Sousa S., and de Souza L. B., Salivary gland tumors in a Brazilian population: a 20-year retrospective and multicentric study of 2292 cases, Journal of Cranio-Maxillo-Facial Surgery. (2018) 46, no. 12, 2227–2233.
Damar, M.; Dinç, A.E.; Erdem, D.; Aydil, U.; Kizil, Y.; Eravcı, F.C.; Bişkin, S.; Şevik Eliçora, S.; Işik, H. Pretreatment Neutrophil-Lymphocyte Ratio in Salivary Gland Tumors Is Associated with Malignancy. Otolaryngol. Head Neck Surg. 2016, 155, 988-996.
Ghaderi, Hamid, Kruger, Estie, Ahmadvand, Simin, Mohammadi, Yousef, Khademi, Bijan, Ghaderi, Abbas, Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: A Retrospective Study of 405 Cases, Journal of Cancer Epidemiology, 2023, 8844535, 11 pages, 2023.
Nardone, V.; Reginelli, A.; Grassi, R.; Boldrini, L.; Vacca, G.; D’Ippolito, E.; Annunziata, S.; Farchione, A.; Belfiore, M.P.; Desideri, I.; et al. Delta radiomics: A systematic review. Radiol. Med. 2021, 126, 1571–1583.
National Cancer Institute. Physician Data Query (PDQ). Salivary Gland Cancer: Treatment. 2019. Accessed at https://www.cancer.gov/types/head-and-neck/hp/adult/salivary-gland-treatment-pdq on April 22, 2021.
Peravali RK, Bhat HH, Upadya VH, Agarwal A, Naag S. Salivary gland tumors: a diagnostic dilemma!. J Maxillofac Oral Surg. 2015;14(Suppl 1):438-442.
Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, Vielh P, Kurtycz DFI. The Milan System for Reporting Salivary Gland Cytopathology: analysis and suggestions of initial survey. Cancer Cytopathol. 2017;125(10):757-766.
Song, L.; Chen, S.; Chen, W.; Shi, Z.; Wang, X.; Song, L.; Chen, D. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images. BMC Med. Imaging 2021, 21, 54.
Thoeny, H.C. Imaging of salivary gland tumours. Cancer Imaging 2007, 7, 52–62.
Zhang, R.; Ai, Q.Y.H.; Wong, L.M.; Green, C.; Qamar, S.; So, T.Y.; Vlantis, A.C.; King, A.D. Radiomics for Discriminating Benign and Malignant Salivary Gland Tumors; Which Radiomic Feature Categories and MRI Sequences Should Be Used? Cancers 2022, 14, 5804.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.